packageEpcoritamab

epcoritamab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Epcoritamab, a monoclonal antibody anticancer drug, is used to treat diffuse large B-cell lymphoma. It is approved and authorised in the European Union, with one authorised product there, and remains under investigation for further uses.

Summary written by glm-5.3-flash from Wikidata Q119025940 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:epcoritamab
ATC codes:L01FX27
DrugBank:DB16672
Wikidata:Q119025940
molar mass:149000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown